Healthcare
Danaher Corporation(DHR)
Live Price
Offline$177.17
-0.33% today
1Y Change
-10.96%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $123.60B
- Revenue Growth
- +2.9%
- EPS Growth
- -4.9%
- Dividend Yield
- 0.8%
Coverage: 249 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Danaher Corporation (DHR) is a Healthcare stock with a market cap of $123.60B and listed on NYSE. The stock last traded around $177.17 and down 11.0% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +2.9%, EPS growth of -4.9%, a dividend yield of 0.8%. What stands out right now is revenue +2.9%, EPS -4.9%, free cash flow -0.7% with operating margin 21.0% and ROIC 5.7%. The dividend is present but secondary, with a yield around 0.8%. Valuation already assumes a fairly strong business story at P/E 33.5 and price/sales 5.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DHR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+2.9% vs +7.6% peer median
Operating Margin
Near sector median
+21.0% vs +19.4% peer median
P/E
Below sector median
33.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 21, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +2.9% and EPS is at -4.9%, with operating margin around 21.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.8%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -4.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 21, 2026 | โ | -5.4% | -8.0% | -14.1% |
2026 Jan 28, 2026 | +3.2% | -2.2% | -2.2% | -6.8% |
2025 Oct 21, 2025 | +9.9% | -1.2% | -1.8% | +2.1% |
Benchmark Edge
DHR vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DHR
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DHR Max Drawdown
-33.11%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for DHR and SPY.
Company Overview
Danaher Corporation
New York Stock Exchange
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
- Leadership
- Rainer Blair
- IPO Date
- Dec 29, 1978
- Employees
- 61.0k
- Street Address
- 2200 Pennsylvania Avenue, NW
- Mailing
- Washington, DC, 20037-1701
- Region
- Washington, DC, US
- Reporting Currency
- USD
- Investor Line
- 202 828 0850
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 33.5
- EV/EBITDA
- 20.4
- Price/Sales
- 5.0
- Price/Book
- 2.3
Growth
- Revenue
- +2.9%
- EPS
- -4.9%
- Free Cash Flow
- -0.7%
Profitability
- Gross Margin
- 60.7%
- Operating Margin
- 21.0%
- Net Margin
- 14.9%
- ROE
- 7.1%
- ROIC
- 5.7%
Balance Sheet
- Debt/Equity
- 0.35
- Current Ratio
- 1.87
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.